Page 46 - MI-2-4

Microbes & Immunity Pulmonary immunity: Pathogens versus protectors

27. Farnia P, Farnia P, Ghanavi J, Ayoubi S, Besharati S, prevalence of Integron 1, 2 and biofilm formation in
Velayati AA. Comparison of proline-glutamate-proline- clinical isolates of Pseudomonas aeruginosa in Tehran, 2024.
glutamate-polymorphic GC-rich sequences family protein J Isfahan Med Sch. 2025;43:125-134.
Wag22 (Rv1759c), PE_PGRS31 (Rv1768), PE_PGRS32 doi: 10.48305/jims.v43.i805.0125
(Rv1803), and PE_PGRS33 gene (Rv1818c) in exponential
state and under in vitro model of latency in same clinical 37. Besharati S, Owlia P, Sadeghi A, et al. Frequency, antibiotic
isolates of Mycobacterium tuberculosis: Frameshift mutation resistance and serogroups of Salmonella among chicken meat
in extensively drug-resistant and totally drug-resistant specimens in Tehran, Iran. Daneshvar Med. 2020;27(4):1-10.
Tuberculosis bacilli. Biomed Biotechnol Res J (BBRJ). doi: 10.1007/s11032-023-01398-w
2023;7(4):621-632.
38. Yang R, Fu D, Liao A. The role of complement in tumor
doi: 10.4103/bbrj.bbrj_271_23 immune tolerance and drug resistance: A double-edged
28. Wang Y, Pruitt RN, Nürnberger T, Wang Y. Evasion of sword. Front Immunol. 2025;16:1529184.
plant immunity by microbial pathogens. Nat Rev Microbiol. doi: 10.3389/fimmu.2025.1529184
2022;20(8):449-464.
39. Chow A, Perica K, Klebanoff CA, Wolchok JD. Clinical
doi: 10.1038/s41579-022-00710-3 implications of T cell exhaustion for cancer immunotherapy.
29. Tanaka Y, Luo Y, O’Shea JJ, Nakayamada S. Janus kinase- Nat Rev Clin Oncol. 2022;19(12):775-790.
targeting therapies in rheumatology: A mechanisms-based doi: 10.1038/s41571-022-00689-z
approach. Nat Rev Rheumatol. 2022;18(3):133-145.
40. Zhang G, Wang J, Zhao Z, et al. Regulated necrosis, a
doi: 10.1038/s41584-021-00726-8 proinflammatory cell death, potentially counteracts
30. Varahram M, Besharati S, Farnia P, et al. Correlation of pathogenic infections. Cell Death Dis. 2022;13(7):637.
single-nucleotide polymorphism at interferon-gamma R1 doi: 10.1038/s41419-022-05066-3
(at position- 56) in positive purified protein derivative health
workers with COVID-19 infection. Int J Mycobacteriol. 41. Gao D, Gao W, Zhai Z, Zhu W. Immune mechanisms and
2022;11(3):318-322. novel therapies for idiopathic pulmonary fibrosis. Pharm Sci
Adv. 2024;2:100030.
doi: 10.4103/ijmy.ijmy_133_22
doi: 10.1016/j.pscia.2023.100030
31. Lei L, Pan W, Shou X, et al. Nanomaterials-assisted gene
editing and synthetic biology for optimizing the treatment 42. Ahmed R, Zaman T, Chowdhury F, et al. Single-cell RNA
of pulmonary diseases. J Nanobiotechnol. 2024;22(1):343. sequencing with spatial transcriptomics of cancer tissues. Int
J Mol Sci. 2022;23(6):3042.
doi: 10.1186/s12951-024-02627-w
doi: 10.3390/ijms23063042
32. Adivitiya, Kaushik MS, Chakraborty S, Veleri S, Kateriya S.
Mucociliary respiratory epithelium integrity in molecular 43. Pelaia C, Tinello C, Vatrella A, De Sarro G, Pelaia G. Lung
defense and susceptibility to pulmonary viral infections. under attack by COVID-19-induced cytokine storm:
Biology (Basel). 2021;10(2):95. Pathogenic mechanisms and therapeutic implications. Ther
Adv Respir Dis. 2020;14:1-9.
doi: 10.3390/biology10020095
doi: 10.1177/1753466620933508
33. Dransfield M, Rowe S, Vogelmeier CF, et al. Cystic fibrosis
transmembrane conductance regulator: Roles in chronic 44. Hsu RJ, Yu WC, Peng GR, et al. The role of cytokines
obstructive pulmonary disease. Am J Respir Crit Care Med. and chemokines in severe acute respiratory syndrome
2022;205(6):631-640. coronavirus 2 infections. Front Immunol. 2022;13:832394.
doi: 10.3389/fimmu.2022.832394
doi: 10.1164/rccm.202109-2064TR
34. Besharati S, Owlia P. Evaluation of biofilm production 45. Stegeman SK, Kourko O, Amsden H, et al. RNA viruses, toll-
capacity in Salmonella isolated from chicken meat in Tehran like receptors, and cytokines: The perfect storm? J Innate
municipally daily fruit and vegetable markets. Daneshvar Immun. 2025;17:126-153.
Med. 2020;28(1):62-72. doi: 10.1159/000543608
35. Besharati S, Farnia P, Farnia P, Ghanavi J, Velayati AA. 46. Lu T, Yan H, Luo J, Wang S, Xia Y, Xu X. Elevated
Investigation of the hypothesis of biofilm formation in thrombosis-related biomarkers as predictors of disease
coronavirus (COVID-19). Biomed Biotechnol Res J (BBRJ). severity and mortality in patients with severe fever with
2020;4(Suppl 1):S99-S100. thrombocytopenia syndrome. BMC Infect Dis. 2025;25:235.
doi: 10.4103/bbrj.bbrj_126_20 doi: 10.1186/s12879-025-10574-6
36. Besharati S, Soleimani N, Rahbar M. Evaluation of the 47. Krishnamachary B, Cook C, Kumar A, Spikes L, Chalise P,

Volume 2 Issue 4 (2025) 38 doi: 10.36922/MI025100019